The genes sharing these GO terms have been previously shown to be involved in breast cancer prognostic process (e.g., CXCR6, KIT, RUNX3) and also immune cell regulation (e.g., CD8B, DAPP1, LY75). Here, KIT is linked to breast carcinoma.